首页> 外文期刊>Journal of Clinical and Diagnostic Research >Multidisciplinary Approach and Pivotal Role of Pathologist in Diagnosis of Breast Cancer: Technological Advances: An Updated Review for Breast Health Care experts
【24h】

Multidisciplinary Approach and Pivotal Role of Pathologist in Diagnosis of Breast Cancer: Technological Advances: An Updated Review for Breast Health Care experts

机译:病理学家在乳腺癌诊断中的多学科方法和关键作用:技术进步:针对乳房健康护理专家的最新评论

获取原文
           

摘要

Clinical and pathological diagnosis of breast carcinoma is advancing at the same pace as the global increase in its incidence, morbidity and mortality. Research scientists (bio molecular, pathologists, clinicians and geneticists) are working on war footing for prevention, cure and treatment of breast cancer. In near future, breast cancer diagnosis may advance inexplicably.The pathology report serves not only as a hard copy for clinicians on which various treatment modalities are based , but also as a teaching module for educated cancer patients. The pathologist, who plays a very critical and pivotal role, hardly meets the patient in most institutional set ups. In unlimited resource centers, his/her role is very critical, because patients themselves can challenge clinicians and sue the pathologist.The scientific document based on observation can be finite, but the pathologist has to go beyond the finite observation, because many technical and clinical variations and limitations have to be taken into consideration. A guarded analytical opinion along with suggestions has to be given for the patient.Diagnosis of breast carcinoma has leaped rapidly from FNAC to DNA with many intermediaries in between. In some institutes, the best possible cost effective diagnosis is given, whereas in others, molecular studies are done to provide the diagnosis which influences the therapeutic and prognostic outlook.
机译:乳腺癌的临床和病理诊断以与全球其发病率,发病率和死亡率不断增加的速度同步发展。研究科学家(生物分子,病理学家,临床医生和遗传学家)正在为预防,治愈和治疗乳腺癌做准备。在不久的将来,乳腺癌的诊断可能会莫名其妙地进展。病理报告不仅可以作为临床医生根据各种治疗方式的印刷本,而且可以作为受过教育的癌症患者的教学模块。病理学家扮演着非常关键和关键的角色,在大多数机构中几乎都无法与患者见面。在无数资源中心中,他/她的角色非常关键,因为患者自己可以挑战临床医生并起诉病理学家。基于观察的科学文献可能是有限的,但是病理学家必须超越有限的观察,因为许多技术和临床必须考虑各种变化和限制。必须为患者提供谨慎的分析意见和建议。乳腺癌的诊断已从FNAC迅速发展为DNA,两者之间有许多中介。在一些机构中,给出了可能的成本效益最好的诊断方法,而在其他机构中,进行了分子研究以提供影响治疗和预后前景的诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号